Who invested in Xenome?
Xenome's investors include QIC BioVentures, GBS Ventures, Amylin Pharmaceuticals, BioCapital and Innovis Investments.
Australia · Venture startup
5 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 5 rounds since 2003, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Reported by xenome.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Xenome's investors include QIC BioVentures, GBS Ventures, Amylin Pharmaceuticals, BioCapital and Innovis Investments.
Xenome has raised $33M across 5 rounds since 2003.
Xenome's most recent round was a Venture of $10M in Apr 2010.
Its most recent round, $10M in Apr 2010, is also its largest on record.
Xenome's first round on record, in Jun 2003, was backed by BioCapital.
Xenome's latest named round is a Venture, in Apr 2010.
Xenome is based in Australia.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.